Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases

Data about safety and efficacy of the mRNA SARS-CoV-2 vaccine in adolescents with rheumatic diseases (RD) is scarce and whether these patients generate a sufficient immune response to the vaccine remains an ou...

Source: Pediatric Rheumatology - August 13, 2022 Category: Rheumatology Authors: Clara Udaondo, Carmen C ámara, Laura Miguel Berenguel, Rosa Alcobendas Rueda, Celia Muñoz Gómez, Claudia Millán Longo, Blanca Díaz – Delgado, Iker Falces-Romero, Mariana Díaz Almirón, Jordi Ochando, Ana Méndez – Echevarría, Agustín Remesal C Tags: Research article Source Type: research